U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts ...
C3.ai stock fell amid a massive rout in artificial intelligence stocks earlier in the week. Is C3.ai stock a sell now? Shares ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.